Gornitzky represented Dan Public Transportation Company Ltd. in the deal. Dan Public Transportation Company Ltd. executed an investment transaction in Symcotech Ltd., which develops, manufactures and...
Dan Public Transportation Company’s Investment in Symcotech
Mivna Group’s Acquisition of Yad Hana Homesh Industries Cooperative Association
Barnea represented Kibbutz Shefayim and Yad Hana on the deal. Mivna Group executed the acquisition of 50% of the shares of the Yad Hana Homesh Industries Cooperative Association...
Skyline Robotics Secures’ $6.5 Million Pre-Series A Funding Round
Skyline Robotics was represented by EBN&Co. Skyline Robotics executed a USD 6.5 million Pre-Series A financing round, led by Standard, and its existing shareholders Kärcher and Gefen...
CareTech Holdings Ltd’s Acquisition of Stake in Wellness Day Surgery LLC
Hogan Lovells advised Wellness Day Surgery LLC on the deal. The transaction concerned the sale of a majority stake in the share capital of Wellness Day...
Hg’s Acquisition of Minority Stake in IFS and WorkWave
White & Case has advised IFS and its shareholders, including EQT, while Latham & Watkins has advised TA Associates on the deal. TA Associates executed the...
Clal and Phoenix’s Appeal Filing
Gornitzky & Co. represented Clal and Phoenix in the deal. Clal and Phoenix filed an appeal with the Supreme Court over a ruling that denied an...
Icon Group’s Acquisition Agreement of Visual DG
FBC&Co advised Icon Group on the deal. Icon Group Ltd. (iDigital) entered into an acquisition agreement of the control of VISUAL D.G. Ltd. at a company value...
Nucleai’s $33 Million Raising Fund
EBN&Co. advised Vertex Ventures, Debiopharm, Grove Ventures and Fosun RZ Capital on the deal, while Yigal Arnon & Co. represented Nucleai. Nucleai raised $33 million in...
Sky Fund’s Acquisition of Shares of Dolce Vita Way of Life
FBC&Co advised Sky Fund on the transaction. Sky Fund executed the acquisition of 50% of the shares of Dolce Vita Way of Life Ltd. at a...
UroGen Pharma’s $100 Million Non-Dilutive Term Loan Financing Agreement with Pharmakon Advisors
EBN&Co. advised UroGen Pharma LTD. on the deal. UroGen Pharma LTD. signed a $ 100 million term loan financing facility with funds managed by Pharmakon Advisors, L.P....
Datagen Technologies’ Series B Financing Round
EBN&Co. advised Datagen on the deal. Datagen Technologies Ltd. executed a USD 50 million Series B financing round, led by Scale Venture Partners together with existing...
More Provident & Pension’s Acquisition of Lev-Ram Building
EBN&Co advised More Provident & Pension on the deal. More Provident & Pension Ltd executed the acquisition of the Lev-Ram building in Jerusalem. The building, was sold by...